PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+9.53%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$5.85B
AUM Growth
+$5.85B
(+8.6%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
2.36%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
136
New
22
Increased
38
Reduced
38
Closed
15
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$131M |
| 2 |
AnaptysBio
ANAB
|
$91.4M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$70.5M |
| 4 |
TSMC
TSM
|
$63.5M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$46.5M |
Top Sells
| 1 |
Baidu
BIDU
|
$89.2M |
| 2 |
Centene
CNC
|
$80.2M |
| 3 |
Hologic
HOLX
|
$75.2M |
| 4 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$68.1M |
| 5 |
Baxter International
BAX
|
$63.9M |
Sector Composition
| 1 | Healthcare | 57.89% |
| 2 | Technology | 15.28% |
| 3 | Communication Services | 6.09% |
| 4 | Consumer Discretionary | 2.77% |
| 5 | Financials | 1.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Viatris
VTRS
$12.3B
| $172M | 2.52% | 4,692,968 +212,248 | +5% | +$7.77M |
|
2
Jazz Pharmaceuticals
JAZZ
$7.75B
| $161M | 2.36% | 958,025 -280,881 | -23% | -$47.2M |
|
3
Elevance Health
ELV
$71.8B
| $146M | 2.13% | 531,690 -175,554 | -25% | -$48.1M |
|
|
AERI
4
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $139M | 2.04% | 2,258,443 -461,775 | -17% | -$28.4M |
|
5
Pacira BioSciences
PCRX
$1.2B
| $138M | 2.01% | 2,797,574 -312,639 | -10% | -$15.4M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $131M | 1.93% | +689,949 | New | +$131M |
|
|
ARNA
7
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $126M | 1.84% | 2,729,555 +1,532,664 | +128% | +$70.5M |
|
|
PTLA
8
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $123M | 1.8% | 4,600,847 -478,923 | -9% | -$12.8M |
|
|
MYOK
9
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $123M | 1.79% | 1,878,909 +59,594 | +3% | +$3.89M |
|
10
Humana
HUM
$36.5B
| $115M | 1.69% | 341,010 +31,909 | +10% | +$10.8M |
|
|
BPMC
11
DELISTED
Blueprint Medicines
BPMC
| $112M | 1.65% | 1,440,038 +595,957 | +71% | +$46.5M |
|
12
Penumbra
PEN
$10.6B
| $109M | 1.59% | 725,401 +151,001 | +26% | +$22.6M |
|
13
DaVita
DVA
$9.85B
| $107M | 1.57% | 1,491,826 +206,826 | +16% | +$14.8M |
|
14
Alphabet (Google) Class A
GOOGL
$2.57T
| $107M | 1.56% | 88,421 -1,353 | -2% | -$1.63M |
|
|
15
AnaptysBio
ANAB
$569M
| $105M | 1.54% | 1,054,361 +916,023 | +662% | +$91.4M |
|
16
Zimmer Biomet
ZBH
$21B
| $100M | 1.47% | 761,934 -132,682 | -15% | -$17.4M |
|
17
Tenet Healthcare
THC
$16.3B
| $96.1M | 1.41% | 3,375,241 -961,705 | -22% | -$27.4M |
|
18
GoDaddy
GDDY
$20.5B
| $93M | 1.36% | 1,115,201 +139,782 | +14% | +$11.7M |
|
19
Intuit
INTU
$186B
| $91.8M | 1.34% | 403,592 +105,006 | +35% | +$23.9M |
|
20
Edwards Lifesciences
EW
$47.8B
| $91M | 1.33% | 522,672 +19,427 | +4% | +$3.38M |
|
21
Abbott
ABT
$231B
| $90M | 1.32% | 1,227,060 -110,228 | -8% | -$8.09M |
|
22
Agilent Technologies
A
$35.7B
| $88M | 1.29% | 1,247,899 +134,830 | +12% | +$9.51M |
|
23
Esperion Therapeutics
ESPR
$448M
| $87.4M | 1.28% | 1,970,134 -490,023 | -20% | -$21.7M |
|
24
Salesforce
CRM
$245B
| $87.1M | 1.28% | 547,686 -176,545 | -24% | -$28.1M |
|
25
Molina Healthcare
MOH
$9.8B
| $85M | 1.25% | 571,571 +33,609 | +6% | +$5M |
|